Alloplex Biotherapeutics, Inc. — Form D
Alloplex Biotherapeutics, Inc. of Woburn, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-13. The offering totals $25.0M, of which $20.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-13
- Form: D
- Accession: 0001762917-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $20.7M
- Remaining: $4.3M
- Investors: 51
- Date of first sale: 2023-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-473268
Issuer
- Name: Alloplex Biotherapeutics, Inc.
- CIK: 0001762917
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 300 Trade Center Drive, Woburn, MA, 01801
- Phone: 857-272-1214
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Francescopalo Borriello | Executive Officer | Woburn, MA |
| Francescopaolo Borriello | Director | Woburn, MA |
| Francescopaolo Borriello | Executive Officer | Woburn, MA |
Other filings by this issuer (2)
More